|
ACCEPT: Afatinib as cancer therapy for exocrine pancreatic tumors–An explorative randomized phase II trial. |
| |
|
Consulting or Advisory Role - Celgene |
Research Funding - Boehringer Ingelheim (Inst); Roche Pharma AG (Inst) |
Travel, Accommodations, Expenses - Boehringer Ingelheim; Celgene |
| |
|
Honoraria - Celgene; Roche Pharma AG |
Consulting or Advisory Role - Celgene |
Research Funding - Celgene (Inst) |
Travel, Accommodations, Expenses - Celgene |
| |
|
No Relationships to Disclose |
| |
|
Honoraria - Amgen; Merck Serono; Pfizer; Roche Pharma AG; Sanofi |
Consulting or Advisory Role - Amgen; Merck Serono; Pfizer; Roche Pharma AG; Sanofi |
Research Funding - Celgene (Inst); Roche Pharma AG (Inst); Sanofi (Inst) |
| |
|
Travel, Accommodations, Expenses - Celgene; Novartis; Roche Pharma AG |
| |
|
Honoraria - Amgen; Bayer Schering Pharma; Celgene; Falk Foundation; Merck Serono; Roche; Sanofi |
Consulting or Advisory Role - Boehringer Ingelheim; Celgene; Lilly; Merck Serono |
Research Funding - Celgene; Sanofi |
Travel, Accommodations, Expenses - Bayer Schering Pharma; Celgene; Merck Serono; Roche; Sanofi |
| |
|
No Relationships to Disclose |
| |
|
Research Funding - Boehringer Ingelheim; Pfizer (Inst); Taiho Pharmaceutical (Inst) |
| |
|
Consulting or Advisory Role - Boehringer Ingelheim; Celgene; Lilly; Merrimack |
Research Funding - Boehringer Ingelheim; Novartis |
Travel, Accommodations, Expenses - Celgene |
| |
|
Honoraria - Boehringer Ingelheim; Celgene; Roche Pharma AG |
Consulting or Advisory Role - Boehringer Ingelheim; Celgene; Roche Pharma AG |
Research Funding - Boehringer Ingelheim (Inst); Celgene (Inst); Roche Pharma AG (Inst) |